Tramadol and Relistor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tramadol (tramadol hydrochloride) and Relistor (methylnaltrexone bromide). Common drug interactions include injection site pain among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Tramadol and Relistor. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Tramadol?

Tramadol has active ingredients of tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 235,798 Tramadol users. Check the latest studies of Tramadol.

What is Relistor?

Relistor has active ingredients of methylnaltrexone bromide. eHealthMe is studying from 1,659 Relistor users. Check the latest studies of Relistor.



On Jul, 03, 2026

39 people who take Tramadol and Relistor together, and have interactions are studied.

Tramadol and Relistor drug interactions.

What are the common drug interactions of Tramadol and Relistor, by gender? *:

female:

  1. Injection site pain
  2. Weight increased
  3. Drug ineffective
  4. Anxiety
  5. Chronic kidney disease
  6. Oropharyngeal pain
  7. Constipation
  8. Diarrhoea
  9. Chest pain
  10. Cough

male:

  1. Drug ineffective
  2. Muscle spasms (muscle contraction)
  3. Pain in extremity
  4. Periarthritis (inflammation of the external coats of an artery and of the tissues around the artery)
  5. Post procedural swelling
  6. Postoperative wound complication
  7. Streptococcal infection
  8. Tendonitis (a condition that causes pain and swelling of tendons)
  9. Pneumonia
  10. Renal pain (kidney pain)

What are the common drug interactions of Tramadol and Relistor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Cerebrospinal fluid leakage
  2. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  3. Pseudomeningocele (abnormal collection of cerebrospinal fluid)
  4. Swelling

30-39:

n/a

40-49:

  1. Drug ineffective
  2. Injection site oedema
  3. Injection site pain
  4. Weight increased
  5. Anxiety
  6. Mood swings (an extreme or rapid change in mood)
  7. Muscle spasms (muscle contraction)

50-59:

  1. Injection site pain
  2. Oropharyngeal pain
  3. Anxiety
  4. Chest pain
  5. Cough
  6. Diarrhoea
  7. Localised infection (infection at the single location)
  8. Tooth infection
  9. Weight increased
  10. Abdominal distension

60+:

  1. Drug ineffective
  2. Chronic kidney disease
  3. Gastrointestinal mucosal exfoliation (mucous membrane comes out and new takes place in gastrointestinal tract)
  4. Headache (pain in head)
  5. Lethargy (tiredness)
  6. Mucous stools (mucous with stool)
  7. Myalgia (muscle pain)
  8. Nausea (feeling of having an urge to vomit)
  9. Neck pain
  10. Retching (strong involuntary effort to vomit)

What are the existing conditions these people have? *

  1. Constipation: 9 people, 23.08%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 20.51%
  3. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 7 people, 17.95%
  4. High Blood Pressure: 5 people, 12.82%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 12.82%
  6. Depression: 3 people, 7.69%
  7. High Blood Cholesterol: 3 people, 7.69%
  8. Stress And Anxiety: 3 people, 7.69%
  9. Oedema (fluid collection in tissue): 3 people, 7.69%
  10. Muscle Spasms (muscle contraction): 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Tramadol and Relistor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tramadol and Relistor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tramadol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Relistor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tramadol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Relistor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on tramadol hydrochloride and methylnaltrexone bromide (the active ingredients of Tramadol and Relistor, respectively), and Tramadol and Relistor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: